GLAXOSMITHKLINE(GSK.UK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

GSK.UK GLAXOSMITHKLINE

Opening Auction 11-04 16:30:00 GMT Delay

1,414.00

-5.50

-0.39%

High1,420.50	Low1,409.00	Vol3.84M
Open1,410.50	D1 Closing1,419.50	Amplitude0.81%
Mkt Cap5.77T	Tradable Cap5.59T	Total Shares4.08B
T/O5.43B	T/O Rate0.10%	Tradable Shares3.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GSK.UK","market":"UK","secType":"STK","nameCN":"GLAXOSMITHKLINE","latestPrice":1414,"timestamp":1730737800000,"preClose":1419.5,"halted":0,"volume":3841299,"delay":15,"nameEN":"GLAXOSMITHKLINE","floatShares":3950456623,"shares":4080499701,"eps":60.78980000000001,"marketStatus":"Opening Auction","change":-5.5,"latestTime":"11-04 16:30:00 GMT Delay","open":1410.5,"high":1420.5,"low":1409,"amount":5434834208,"amplitude":0.008101,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":60.78980000000001,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1730793600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"LSE","adjPreClose":1419.5,"openAndCloseTimeList":[[1730793600000,1730824200000]],"volumeRatio":0.4882663389436942,"tradeCurrency":"GBX","tradeService":"SETS","exchangeMarketSize":1000},"requestUrl":"/m/hq/s/GSK.UK","defaultTab":"news","newsList":[{"id":"2480023653","title":"Press Release: Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2480023653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480023653?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:30","pubTimestamp":1730723400,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors. NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  , a leader in the development of Antibody Radiation Conjugates  and other targeted radiotherapies, today announced the appointment of June Almenoff, M.D., Ph.D. to its Board of Directors. Dr. Almenoff is an accomplished biopharma executive with over 25 years of senior leadership and drug development experience. She currently serves as a Board Director and advisor to numerous biopharma companies.Dr. Almenoff has strong expertise in translational medicine, clinical development, commercial strategy, and business development across many therapeutic areas, and has led or contributed to numerous regulatory submissions, product approvals and launches. She is a member of the investment advisory board of the Harrington Discovery Institute, a director on the board of Avalo Therapeutics, Inc.  and T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","GSK","GSK.UK","BK4588","BK4585","BK4532","R","BK4232","BK4139","LU1829250122.USD","BK4022","BK4007"],"gpt_icon":0},{"id":"2480348381","title":"M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2480348381","media":"seekingalpha","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480348381?lang=en_us&edition=fundamental","pubTime":"2024-11-03 03:34","pubTimestamp":1730576040,"startTime":"0","endTime":"0","summary":"Edwin Tan  Companies that grabbed headlines in the deals space include: AbbVie  has agreed to acquire all outstanding equity of neuroscience-focused biotech Aliada Therapeutics for $1.4B in cash. Stericycle  disclosed that all the closing conditions for its planned $ 62-a-share sale to Waste Management  have been received. Maersk  CEO Vincent Clerc said the shipping and logistics company won't be participating in the GXO Logistics  sales process. Blackstone  is the mystery investor who bid for a $7 billion minority stake in Roger Communication Inc.'s  cell phone infrastructure business. Siemens   agreed to buy Altair Engineering  for $113 a share in cash, or a total deal value of $10.6 billion, the companies announced Wednesday. Take-Two Interactive  ticks higher on report it's in talks to sell adtech division. Cleveland-Cliffs  said it won the final approvals needed for its planned $2.5 billion purchase of Stelco  and the deal is scheduled to close on Friday. GSK  has agreed to acquir","market":"other","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1420639945/image_1420639945.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1420639945/image_1420639945.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4233378-ma-deals-roundup-abbvie-blackstone-take-two-interactive-and-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["PSQ","TTWO","CLF","STZHF","LU0795875169.SGD","LU2298064838.USD","GSK","SMAWF","NQmain","LU0175139822.USD","QID","BX","LU0052756011.USD","AMKBY","SRCL","LU0061475181.USD","LU1939255532.USD","LU2211814178.USD","LU1815336091.USD","GXO","LU0965509101.SGD","IE0009355771.USD","BK4532","PARA","TRUE","LU0203345920.USD","QLD","LU2106854487.HKD","GLYC","BK4021",".IXIC","ALTR","BK4006","SQQQ","LU0069063385.USD","WM","MNQmain","RCI","RPD","LU0640476718.USD","BK4007","AVTE","GSK.UK","LU0211327993.USD","LU0689626769.HKD","ABBV","TQQQ","LU0057025933.USD","SIEGY"],"gpt_icon":1},{"id":"2480836383","title":"GlaxoSmithKline Updates Share Capital and Voting Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2480836383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480836383?lang=en_us&edition=fundamental","pubTime":"2024-11-01 23:47","pubTimestamp":1730476038,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline (GSK) has announced that its issued share capital as of October 31, 2024, consists of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/glaxosmithkline-updates-share-capital-and-voting-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/glaxosmithkline-updates-share-capital-and-voting-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4007","GSK","LU1829250122.USD","GSK.UK","BK4585","BK4588"],"gpt_icon":0},{"id":"2480011285","title":"GlaxoSmithKline (GSK) Receives a Hold from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2480011285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480011285?lang=en_us&edition=fundamental","pubTime":"2024-11-01 09:47","pubTimestamp":1730425637,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst David Evans maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) on October 30 and set a price target of p1,5...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-kepler-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-kepler-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4532","GSK","GSK.UK","BK4007","LU1829250122.USD"],"gpt_icon":0},{"id":"2479704603","title":"GSK : Guggenheim Cuts to Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2479704603","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479704603?lang=en_us&edition=fundamental","pubTime":"2024-10-31 19:13","pubTimestamp":1730373182,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nFWN3M713R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1098665638.USD","LU0575583348.USD","LU0545562505.USD","LU1202635105.USD","LU0211331839.USD","LU0203347892.USD","LU1228905037.USD","LU0321505868.SGD","IE00BWDBJ516.SGD","LU0225771236.USD","LU1015430645.USD","LU1481599808.USD","LU1302929846.USD","LU1487256676.USD","IE00BQJZX424.USD","LU0109981661.USD","LU1035777561.USD","LU0321505439.SGD","LU1400636574.HKD","BK5011","LU1670756490.USD","LU0203345920.USD","LU0971552830.HKD","LU1400636491.USD","GSK.UK","LU0289739699.SGD","LU1400636657.SGD","LU0058720904.USD","LU0985481810.HKD","LU1064927863.SGD","LU0225284248.USD","LU1645745479.HKD","LU1481600234.SGD","IE0034235071.USD","LU1046248800.SGD","LU1228905540.USD","LU0971552673.USD"],"gpt_icon":0},{"id":"2479017782","title":"GSK's 3Q Results Are a Mixed Bag -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2479017782","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479017782?lang=en_us&edition=fundamental","pubTime":"2024-10-30 23:04","pubTimestamp":1730300640,"startTime":"0","endTime":"0","summary":"1504 GMT - GSK's 3Q performance was mixed, with a profit beat but weakened vaccines sales, Barclays analysts say in a note. The British pharma giant delivered expectations at the group level but missed sales estimates for its key vaccine shots that led the company to lower its annual vaccine segment outlook, they say. Investors' focus will be on the sales outlook for the next two years for its RSV vaccine Arexvy and its best-selling shingles vaccine Shingrix, Barclays says. Shares fall 3.6% to 14 pounds. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","BK4585","BK4588","GSK","GSK.UK","BK4007","BK4532"],"gpt_icon":0},{"id":"2479781432","title":"GSK Insider Purchases Signal Confidence in Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2479781432","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479781432?lang=en_us&edition=fundamental","pubTime":"2024-10-30 22:32","pubTimestamp":1730298737,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline (GB:GSK) has released an update. GSK’s Non-Executive Chair’s associate, Lady Susan Symonds, has acquired 7,150 ordinary shares at £...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-insider-purchases-signal-confidence-in-company?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-insider-purchases-signal-confidence-in-company?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","GSK","LU1829250122.USD","GSK.UK","BK4007","BK4585"],"gpt_icon":0},{"id":"2479078751","title":"Biggest stock movers Wednesday: SMCI, LLY, GOOG, SNAP, and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2479078751","media":"seekingalpha","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479078751?lang=en_us&edition=fundamental","pubTime":"2024-10-30 22:15","pubTimestamp":1730297722,"startTime":"0","endTime":"0","summary":"Donny DBM/iStock via Getty Images Stock futures were trading mixed on Wednesday after Google's strong Q3 earnings report. Investors are now looking forward to earnings releases from Meta and Microsoft","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2176574609/image_2176574609.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2176574609/image_2176574609.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4221935-biggest-stock-movers-wednesday-goog-snap-and-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU1829250122.USD","LU0354030438.USD","LU0882574055.USD","LU1861220033.SGD","LU0456855351.SGD","BK4141","BK4532","LU0823421333.USD","KHC","LU0106261372.USD","BK4547","IE00B1BXHZ80.USD","LU0130517989.USD","IE0004445239.USD","LU0130518102.USD","LU1880398471.USD","LU2098885051.SGD","LLY","BK4514","LU0158827948.USD","SMCI","BK4077","IE00B3S45H60.SGD","GSK.UK","LU0215105999.USD","AMD","BK4533","IE0034235188.USD","IE00BFSS7M15.SGD","GOOG","IE0004091025.USD","LU0170899867.USD","GSK","IE00BJJMRZ35.SGD","IE0004086264.USD","GOOGL","SNAP","LU0072461881.USD","LU0640476718.USD","LU0820561818.USD","LU0079474960.USD","IE00B5TLWC47.USD","LU0081259029.USD","LU0130103400.USD","LU0882574139.USD","LU2250418816.HKD","LU1880398554.USD","IE00B7KXQ091.USD"],"gpt_icon":1},{"id":"2479200044","title":"Sector Update: Health Care Stocks Decline Premarket Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2479200044","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479200044?lang=en_us&edition=fundamental","pubTime":"2024-10-30 21:19","pubTimestamp":1730294386,"startTime":"0","endTime":"0","summary":"Health care stocks were declining premarket Wednesday with the iShares Biotechnology ETF  slightly lower and the Health Care Select Sector SPDR Fund  down 1.4% recently.Eli Lilly  shares fell by over 10% after the company reported Q3 adjusted earnings and revenue that missed analysts' expectations. The company also lowered its full-year 2024 adjusted earnings per share guidance.GSK  shares were down over 4% after the company reported lower Q3 core earnings and turnover.LivaNova  shares were up over 9% after the company reported higher Q3 adjusted earnings and revenue. The company also raised its full-year guidance for adjusted earnings per share and revenue growth.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","LU0058720904.USD","IE00BK4W5M84.HKD","GSK.UK","LLY","GSK","LU0122379950.USD","LU0385154629.USD","LU0820561909.HKD","LU1023059063.AUD","LU0882574055.USD","LU0256863902.USD","IE00BFTCPJ56.SGD","BK4534","LU1069344957.HKD","LU0943347566.SGD","BK4516","LU0097036916.USD","LIVN","BK4007","LU0882574139.USD","LU0823416689.USD","BK4533","IE0009355771.USD","IE0004445239.USD","LU0203201768.USD","IE00BK4W5L77.USD","BK4581","LU0820561818.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU0456855351.SGD","IE0002141913.USD","LU0096364046.USD","LU1057294990.SGD","LU0256863811.USD","LU0640476718.USD","LU1829250122.USD","XLV","LU0354030438.USD","LU0094547139.USD","LU0198837287.USD","LU0006306889.USD","LU0672654240.SGD","IE00B4R5TH58.HKD","IBB","LU0114720955.EUR","LU0708995401.HKD","BK4585","LU0417517546.SGD"],"gpt_icon":1},{"id":"2479014582","title":"GSK to acquire CMG1A46 from Chimagen Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2479014582","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479014582?lang=en_us&edition=fundamental","pubTime":"2024-10-30 20:15","pubTimestamp":1730290517,"startTime":"0","endTime":"0","summary":"GSK Earnings this Week: How Will it Perform?GSK Pharma put volume heavy and directionally bearish. JMP Securities healthcare analysts hold an analyst/industry conference call","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xBumZ4QcpNk7wPW_.v5BJw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/060c7819ab2e6aac03de78d24e089052","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xBumZ4QcpNk7wPW_.v5BJw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/060c7819ab2e6aac03de78d24e089052"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/gsk-acquire-cmg1a46-chimagen-biosciences-121517169.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gsk-acquire-cmg1a46-chimagen-biosciences-121517169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","GSK","BK4007","GSK.UK","BK4585","BK4532","LU1829250122.USD"],"gpt_icon":0},{"id":"2479827737","title":"GlaxoSmithKline (GSK) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2479827737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479827737?lang=en_us&edition=fundamental","pubTime":"2024-10-30 18:48","pubTimestamp":1730285302,"startTime":"0","endTime":"0","summary":"Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p2,610.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-buy-from-bernstein?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-buy-from-bernstein?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK","BK4588","BK4532","BK4585","GSK.UK","BK4007"],"gpt_icon":0},{"id":"2479606273","title":"GSK CEO When Asked About Catalent Takeover: Not Concerned About GSK's Manufacturing Capacity Moving Forward, No Comment on Deal -Media Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2479606273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479606273?lang=en_us&edition=fundamental","pubTime":"2024-10-30 17:44","pubTimestamp":1730281447,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nFWN3M60MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU0109981661.USD","LU1046248800.SGD","LU1228905037.USD","LU1645745479.HKD","LU1481599808.USD","LU0058720904.USD","LU0225771236.USD","LU1015430645.USD","LU1098665638.USD","LU1202635105.USD","LU0545562505.USD","LU0225284248.USD","LU0971552673.USD","LU0203345920.USD","BK5011","IE00BQJZX424.USD","LU1035777561.USD","LU1302929846.USD","IE00BWDBJ516.SGD","LU0575583348.USD","LU1064927863.SGD","LU0321505439.SGD","LU1228905540.USD","LU1400636491.USD","LU1481600234.SGD","LU1487256676.USD","LU1400636657.SGD","LU0211331839.USD","LU0985481810.HKD","IE0034235071.USD","LU0321505868.SGD","GSK.UK","LU0971552830.HKD","LU1400636574.HKD","LU1670756490.USD","LU0203347892.USD"],"gpt_icon":0},{"id":"2479297722","title":"GSK's Vaccine Weakness Is a Major Concern -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2479297722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479297722?lang=en_us&edition=fundamental","pubTime":"2024-10-30 16:22","pubTimestamp":1730276520,"startTime":"0","endTime":"0","summary":"0822 GMT - GSK's vaccine weakness is the major concern among its 3Q results and could threaten the company's mid-term sales outlook, Intron Health analysts say in a note. The British Pharma giant confirmed its 2024 outlook, including its overall sales forecast. However, it cut annual vaccine sales guidance to low-single digits, from its prior low to mid-single digit range. The vaccine sales target cut follows a 21% miss by its respiratory syncytial virus vaccine Arexvy and a 13% miss by its best-selling shingles vaccine Shingrix, analysts say. \"Our biggest concern is the impact on mid-term sales growth from the weakening vaccines outlook and cost increases ahead of new launches next year,\" they say. Shares are down 2.1% at 14.22 pounds. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GSK","BK4585","LU1829250122.USD","GSK.UK","BK4532","BK4588"],"gpt_icon":0},{"id":"2479229151","title":"BUZZ-GSK falls on slashing annual vaccines forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2479229151","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479229151?lang=en_us&edition=fundamental","pubTime":"2024-10-30 16:08","pubTimestamp":1730275718,"startTime":"0","endTime":"0","summary":"BUZZ-GSK falls on slashing annual vaccines forecast ** Shares in GSK GSK.L down as much as 3.5% at 1400p, lowest level since December 2023** Stock among top losers on FTSE 100 .FTSE index ** British drugmaker cuts 2024 vaccine sales forecast hit by weak demand for its respiratory syncytial virus  and shingles vaccines** Now sees FY vaccine sales down by low-single digit percentage vs previous forecast of low-to-mid-single digit percentage growth** Posts Q3 core EPS of 49.7p, sales of 8.01 bln pounds  vs analyst estimates of EPS of 43.6p, sales of about 8 bln pounds** Up to last close, stock had been largely flat so far this year   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nL4N3M60UC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1098665638.USD","LU0289739699.SGD","LU0971552673.USD","LU0225771236.USD","LU0575583348.USD","IE00BWDBJ516.SGD","LU0211331839.USD","LU1046248800.SGD","LU0225284248.USD","LU1645745479.HKD","LU1487256676.USD","LU0109981661.USD","LU0971552830.HKD","LU1302929846.USD","LU0203345920.USD","LU1400636574.HKD","BK5011","LU1400636491.USD","LU1015430645.USD","LU1670756490.USD","LU1228905037.USD","LU0203347892.USD","IE0034235071.USD","LU1481600234.SGD","LU0985481810.HKD","LU1228905540.USD","LU1035777561.USD","LU1481599808.USD","LU0321505439.SGD","GSK.UK","LU1064927863.SGD","LU0058720904.USD","LU1202635105.USD","LU0321505868.SGD","IE00BQJZX424.USD","LU1400636657.SGD","LU0545562505.USD"],"gpt_icon":0},{"id":"2479226578","title":"GSK Shares Fall 2.2% After Lowering 2024 Vaccine Sales Forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2479226578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479226578?lang=en_us&edition=fundamental","pubTime":"2024-10-30 16:03","pubTimestamp":1730275435,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nL8N3M60SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109981661.USD","LU1645745479.HKD","LU0545562505.USD","LU1302929846.USD","LU0058720904.USD","LU0211331839.USD","LU0203345920.USD","LU0203347892.USD","LU1400636491.USD","LU1481600234.SGD","LU1202635105.USD","LU0321505439.SGD","LU0225284248.USD","LU1015430645.USD","LU1064927863.SGD","LU1228905540.USD","IE00BQJZX424.USD","LU0289739699.SGD","IE00BWDBJ516.SGD","LU1400636574.HKD","LU0971552830.HKD","LU1035777561.USD","LU1046248800.SGD","IE0034235071.USD","LU1228905037.USD","LU0225771236.USD","GSK.UK","LU1400636657.SGD","LU1098665638.USD","LU1670756490.USD","LU0971552673.USD","LU0575583348.USD","LU0985481810.HKD","BK5011","LU1487256676.USD","LU1481599808.USD","LU0321505868.SGD"],"gpt_icon":0},{"id":"2479822339","title":"GSK: Zantac settlements hit profit but  guidance unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2479822339","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479822339?lang=en_us&edition=fundamental","pubTime":"2024-10-30 15:32","pubTimestamp":1730273561,"startTime":"0","endTime":"0","summary":"Total sales in the third quarter were 8bn, down by two per cent on an actual exchange rate basis and up by two per cent on a constant exchange rate basis.Core operating profit rose by five per cent, and core earnings per share rose by five per cent, GSK said. GSK confirmed its 2024 guidance, with turnover growth expected at seven to nineper cent, core operating profit growth at 11 per cent to 13 per cent and core earnings per share growth of 10 per cent to 12 per cent.Vaccines sales fell by 15 per cent, while sales of speciality medicines and general medicines rose by 19 per cent and seven per cent, respectively.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/07/gsk-getty-57ff73d48ba8f-57ff73d497e8c.webp?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/07/gsk-getty-57ff73d48ba8f-57ff73d497e8c.webp?w=286&h=161&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.cityam.com/gsk-zantac-settlements-hit-profit-but-guidance-unchanged/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["LU1829250122.USD","GSK","BK4588","BK4532","BK4007","GSK.UK","BK4585"],"gpt_icon":0},{"id":"1119966774","title":"GSK Cuts 2024 Vaccine Sales Forecast for Second Time This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1119966774","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119966774?lang=en_us&edition=fundamental","pubTime":"2024-10-30 15:20","pubTimestamp":1730272807,"startTime":"0","endTime":"0","summary":"Oct 30  - GSK lowered its 2024 vaccine sales forecast for the second time this year on Wednesday, hit by weak demand for its respiratory syncytial virus  and shingles vaccines.The British drugmaker now expects 2024 vaccine sales to decrease by low-single digit percentage in turnover. It had previously expected the business to grow by a low to mid-single digit percentage.The company reported core earnings per share of 49.7 pence on sales of 8.01 billion pounds  for the third quarter ended Sept. 3","market":"uk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"c0d77e622a6742cf8335299f8317b4b4","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GSK Cuts 2024 Vaccine Sales Forecast for Second Time This Year","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","GSK.UK"],"gpt_icon":1},{"id":"2479924095","title":"GSK Reiterates Guidance As HIV And Cancer Drug Demand Offset Vaccine Weakness -- MarketWatch","url":"https://stock-news.laohu8.com/highlight/detail?id=2479924095","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479924095?lang=en_us&edition=fundamental","pubTime":"2024-10-30 15:18","pubTimestamp":1730272680,"startTime":"0","endTime":"0","summary":"U.K. drugmaker GSK  reiterated its 2024 guidance though it said there was lower than anticipated vaccine demand in the third quarter. GSK said its third-quarter core earnings per share fell 1% to 49.7 pence as revenue fell 2% to GBP8.01 billion. Vaccine sales fell 15% while specialty medicine sales rose 19%. At constant exchange rates it's still expecting revenue growth of 7% to 9%, core operating profit growth of 11% to 13% and core EPS growth of 10% to 12%.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSK","BK4588","BK4532","BK4585","GSK.UK","BK4007"],"gpt_icon":0},{"id":"2479240982","title":"GSK reiterates guidance as HIV and cancer drug demand offset vaccine weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2479240982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479240982?lang=en_us&edition=fundamental","pubTime":"2024-10-30 15:18","pubTimestamp":1730272680,"startTime":"0","endTime":"0","summary":"U.K. drugmaker GSK  reiterated its 2024 guidance though it said there was lower than anticipated vaccine demand in the third quarter. GSK said its third-quarter core earnings per share fell 1% to 49.7 pence as revenue fell 2% to GBP8.01 billion. Vaccine sales fell 15% while specialty medicine sales rose 19%. At constant exchange rates it's still expecting revenue growth of 7% to 9%, core operating profit growth of 11% to 13% and core EPS growth of 10% to 12%.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSK","BK4588","BK4532","BK4007","GSK.UK","BK4585"],"gpt_icon":0},{"id":"2479275922","title":"UPDATE 3-GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2479275922","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479275922?lang=en_us&edition=fundamental","pubTime":"2024-10-30 15:13","pubTimestamp":1730272420,"startTime":"0","endTime":"0","summary":"UPDATE 3-GSK warns of lower 2024 vaccine sales after weaker RSV, shingles demandGSK cuts 2024 vaccine sales forecast for second time this yearStrong specialty medicines offset lower vaccine sales, says CEOQ3 EPS beats market expectations  Shares down 4% in early tradeUpdates shares in bullet point and paragraphs 1 and 15, adds context in paragraph 3By Yadarisa Shabong and Maggie Fick","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nL4N3M60R1:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0262},{"period":"1month","weight":-0.0312},{"period":"3month","weight":-0.0618},{"period":"6month","weight":-0.1884},{"period":"1year","weight":0.0519},{"period":"ytd","weight":0.0021}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":-0.0097},{"period":"3month","weight":0.0305},{"period":"6month","weight":-0.0033},{"period":"1year","weight":0.1438},{"period":"ytd","weight":0.0904}],"compareStock":{"symbol":"ISF.UK","name":"FTSE100 ETF"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.013575},{"month":2,"riseRate":0.541667,"avgChangeRate":-0.00121},{"month":3,"riseRate":0.625,"avgChangeRate":0.009039},{"month":4,"riseRate":0.75,"avgChangeRate":0.03211},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.009346},{"month":6,"riseRate":0.541667,"avgChangeRate":-0.000138},{"month":7,"riseRate":0.458333,"avgChangeRate":-0.003053},{"month":8,"riseRate":0.541667,"avgChangeRate":0.000671},{"month":9,"riseRate":0.541667,"avgChangeRate":-0.00436},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.004055},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.006487},{"month":12,"riseRate":0.608696,"avgChangeRate":0.015835}],"exchange":"LSE","name":"GLAXOSMITHKLINE","nameEN":"GLAXOSMITHKLINE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GLAXOSMITHKLINE(GSK.UK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GLAXOSMITHKLINE(GSK.UK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GLAXOSMITHKLINE,GSK.UK,GLAXOSMITHKLINE股票,GLAXOSMITHKLINE股票老虎,GLAXOSMITHKLINE股票老虎国际,GLAXOSMITHKLINE行情,GLAXOSMITHKLINE股票行情,GLAXOSMITHKLINE股价,GLAXOSMITHKLINE股市,GLAXOSMITHKLINE股票价格,GLAXOSMITHKLINE股票交易,GLAXOSMITHKLINE股票购买,GLAXOSMITHKLINE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GLAXOSMITHKLINE(GSK.UK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GLAXOSMITHKLINE(GSK.UK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction